A Comparison Of Rituximab vs. Iodine I 131 Tositumomab Therapeutic Regimen (i.e., BEXXAR®) For Patients With Relapsed Follicular Non-Hodgkins Lymphoma

This study has been terminated.

Study NCT00268983 Information provided by GlaxoSmithKline

First Received: December 21, 2005 Last Updated: May 15, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given